beta-Thioguanidine deoxyriboside: Target Organs and Levels of Evidence for TR-057
Bioassay of ß-TGdR for Possible Carcinogenicity (CASRN 789-61-7)
| Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| beta-Thioguanidine deoxyriboside 789-61-7 |
02/18/1978 | Intraperitoneal Injection R: 0,3.5,7, M: 0,1,4 MG/KG/35 PER GROUP |
Southern Research Institute |
Levels of Evidence
Male Rats: Equivocal
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|
Female Rats: Positive
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|